Neoplastic Process – Page 35

Moderna and Merck’s Cancer Vaccine Shows Promising Results in Combination with Keytruda

11 months ago talkbio0Tagged ASCO, Beginning, Cancer Vaccines, Keytruda, melanoma, Merck, Moderna, pilot program, RNA, Messenger, United States Food and Drug Administration

Moderna, Merck, Cancer Vaccine, Keytruda, Melanoma, mRNA Technology, ASCO, FDA, Rare Disease, START Pilot Program

RayzeBio Warned of Potential Actinium Isotope Supply Issues Before $4.1B BMS Deal

11 months ago talkbio0Tagged actinium-225, Isotope Supply, Myers, Neoplasms, Neurosecretory Systems, Radiopharmaceuticals, RayzeBio, squibb

RayzeBio, Bristol Myers Squibb, Actinium-225, Isotope Supply Issues, Radiopharmaceuticals, Neuroendocrine Tumors

ASCO 2024: Bristol Myers Squibb’s Opdivo-Yervoy Combo Challenges Roche and AstraZeneca in First-Line Liver Cancer Treatment

11 months ago talkbio0Tagged 2024, ASCO, AstraZeneca, CheckMate-9DW, first-line, Immunotherapy, Liver and Intrahepatic Biliary Tract Carcinoma, Myers, Opdivo-Yervoy, Roche (company), squibb

ASCO 2024, Opdivo-Yervoy, Bristol Myers Squibb, Liver Cancer, First-Line Treatment, Roche, AstraZeneca, Immunotherapy, CheckMate-9DW

Akeso and Summit’s Keytruda-Topping Results in NSCLC Generate Significant Interest at ASCO

11 months ago talkbio0Tagged Akeso, ASCO, Ivonescimab, Keytruda, Malignant Neoplasms, Non-Small Cell Lung Carcinoma, PDCD1 gene, summit, Vascular Endothelial Growth Factor A

Akeso, Summit, Keytruda, NSCLC, ASCO, Merck, Ivonescimab, PD-1, VEGF, Cancer Treatment

Illumina’s Board Approves Spin-Off of Grail, a Cancer Diagnostics Firm

11 months ago talkbio0Tagged Diagnostics, DNA Sequence, Grail, Illumina, Malignant Neoplasms

Illumina, Grail, spin-off, cancer diagnostics, DNA sequencing

GSK Faces Major Setback in Zantac Litigation as Judge Allows Over 70,000 Lawsuits to Proceed

11 months ago talkbio0Tagged court, Delaware, Judge, Malignant Neoplasms, Medinilla, NDMA, ranitidine, SmithKline Beecham, Zantac

GSK, Zantac, Lawsuits, Cancer, Delaware Court, Judge Vivian Medinilla, Ranitidine, NDMA, Pharmaceuticals

AstraZeneca and Daiichi Sankyo’s Enhertu Makes History in HER2-Ultralow Breast Cancer Treatment

11 months ago talkbio0Tagged Antibody-Drug Conjugates, ASCO, AstraZeneca, Carcinoma breast stage IV, Daiichi, Deruxtecan, Enhertu, Malignant neoplasm of breast, Sankyo, trastuzumab

Enhertu, AstraZeneca, Daiichi Sankyo, HER2-Ultralow Breast Cancer, ASCO, Metastatic Breast Cancer, Trastuzumab Deruxtecan, Antibody-Drug Conjugate (ADC), Breast Cancer Treatment

BMS Details Confirmatory Trial Win for KRAS Inhibitor Krazati

11 months ago talkbio0Tagged Accelerated, Approved, Confirmatory Trial, Inhibitor, K-ras Oncogene, KRAZATI, Myers, Non-Small Cell Lung Carcinoma, Pharmacotherapy, Progression-Free Survival, squibb, United States Food and Drug Administration

Bristol Myers Squibb, Krazati, KRAS inhibitor, confirmatory trial, non-small cell lung cancer (NSCLC), progression-free survival (PFS), chemotherapy, accelerated approval, FDA